A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders ...

Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders characterized by the clonal ...

Conclusion Our data suggest that age and HBcrAg rather than HBsAg, are associated with HBV-specific T cell responses. Finally, very low antigen levels indicated by HBsAg and in particular HBcrAg may ...

Poor physical performance in patients with non-Hodgkin lymphoma receiving CAR T-cell therapy was linked to worse survival and increased risk of neurotoxicity in a cohort study.

New pathways discovered for drugs to act on cells Previously unknown access points in cell membrane proteins have been discovered, enabling laboratory-developed drugs to modify cell function Date ...

Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine ...

Shuai Chen, MD https://orcid.org/0009-0007-8628-4313 Department of Neurology, The People’s Hospital of Zhengzhou University and Henan Provincial People’s Hospital ...

Mangione's lawyer, Karen Friedman Agnifilo, has argued that Mangione can't mount a defense if he has to store all of the 15,000 pages of disclosed prosecution evidence in his New York prison cell.